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Cheng Yang1,2*, Tongyu Zhu1,2,5* and Ruiming Rong1,2,4*Abstract
Background: NKT cells play a protective role in ischemia reperfusion (IR) injury, of which the trafficking in the body
and recruitment in injured organs can be influenced by immunosuppressive therapy. Therefore, we investigated the
effects of rapamycin on kidneys exposed to IR injury in early stage and on trafficking of NKT cells in a murine
model.
Material and methods: Balb/c mice were subjected to kidney 30 min ischemia followed by 24 h reperfusion.
Rapamycin (2.5 ml/kg) was administered by gavage daily, starting 1 day before the operation. Renal function and
histological changes were assessed. The proportion of NKT cells in peripheral blood, spleen and kidney was
detected by flow cytometry. The chemokines and corresponding receptor involved in NKT cell trafficking were
determined by RT-PCR and flow cytometry respectively.
Results: Rapamycin significantly improved renal function and ameliorated histological injury. In rapamycin-treated
group, the proportion of NKT cells in spleen was significantly decreased but increased in peripheral blood and kidney.
In addition, the CXCR3+ NKT cell in the kidney increased remarkably in the rapamycin-treated group. The chemokines,
CXCL9 and CXCL10, as the ligands of CXCR3, were also increased in the rapamycin-treated kidney.
Conclusions: Rapamycin may recruit NKT cells from spleen to the IR-induced kidney to ameliorate renal IR injury in the
early stage.
Keywords: Rapamycin, Renal ischemia reperfusion injury, NKT cell, ChemokineIntroduction
Ischemia-reperfusion (IR) injury, an inevitable impair-
ment during renal transplant surgery, remains one of the
major causes of acute kidney injury and represents the
most prominent factor leading to delayed graft function
after transplantation [1].
Immunosuppressive therapy is necessary for patients re-
ceiving organ transplantation, but it affects the resolution
of tissue damage induced by IR injury [2]. Recent years, it* Correspondence: esuperyc@163.com; tyzhu_dr@163.com;
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unless otherwise stated.has seen a heated argument focusing on the effect of rapa-
mycin, a kind of mTOR inhibitor, on ischemic acute kidney
injury. Many studies indicated a damage-promoting role of
rapamycin during IR injury through such mechanisms as
increase of NF-κB activity [3], pro-apoptosis [4], promotion
of renal oxidative/nitrosative stress [5] and aggravation of
tissue infiltration of leukocytes [6]. There was also evi-
dence, however, indicating that rapamycin inhibited apop-
tosis by preventing phosphorylation of pro-apoptotic
protein such as p53 and activation of mitochondrial cell
death pathway [7]. In addition, rapamycin enabled to en-
rich CD4+CD25+Foxp3+ regulatory T (Treg) cells to exert
anti-inflammatory effects during IR process [8]. Our pre-
liminary work showed that rapamycin attenuated renal IR
injury at the early stage (1d after IR) but aggravated it at
the late stage (7d after IR).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 The sequences of the primers
Gene name Primer sequence
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ceptors (TCRs) an natural killer cell receptors, have been
thought as a bridge between the innate and adaptive im-
mune systems [9]. Specific to the murine model, NKT cells
express both the surface marker of T cells—CD3 and that
of NK cells—NK1.1, which can be used to identify NKT
cells in murine tissues. NKT cells can migrate in response
to ligands for the inflammatory chemokine receptors
CXCR3 (CXCL9 and CXCL10) and CXCR6 (CXCL16),
and regulatory chemokine receptors CCR7 (secondary
lymphoid-tissue chemokine (SLC) and CCL21), CXCR4
(stromal cell-derived factor-1 and CXCL12), and CXCR5
(B cell-attracting chemokine-1 and CXCL13); but not to li-
gands for other chemokine receptors [10]. NKT cells have
recently been reported to regulate autoimmune disease
and allogeneic immune response in according animal
models [11,12]. Notably, relevant research demonstrated a
significant protective role for NKT cells in acute kidney in-
jury caused by ischemia reperfusion. Modulation of cellular
infiltration and cytokine expressions along with molecular
changes such as hypoxia-inducible factor-1α and IL-10 are
the main mechanisms for protection [13].
Thus, on the basis of the knowledge of the compre-
hensive regulatory effects of rapamycin on immune sys-
tem and a significant renal protective function of NKT
cells, we hypothesized that rapamycin may protect IR-
induced kidney injury at the early stage through recruit-
ing NKT cells from periphery to the injured site.
Materials and methods
Materials
Rapamycin oral solution (East China Pharmaceutical, Co
Ltd., Hangzhou, China) was diluted in normal saline (1:10)
for gastric gavage.
Renal ischemia reperfusion injury model
Male BALB/c mice (weighing 20-25 g), were obtained
from Shanghai Slac Lab Animal, Co., Ltd, and bred in an
experimental animal room of SPF grade. All animal proce-
dures were performed according to the guidelines of the
Care and Use of the Laboratory Animal Ethical Commis-
sion of Fudan University. Mice were randomly divided into
three groups (n = 5): (1) Sham group; (2) IR group: IR in-
jury with 0.5 ml normal saline gavage; (3) Rapa group: IR
injury with 0.5 ml diluted Rapamycin suspension gavage at
24 h, 1 h before operation, as well as 12 h after operation.
For the renal IR model, the mice were anaesthetized with
pentobarbital at a dosage of 0.1 g/kg body weight intraperi-
toneally. Core body temperature was maintained at 37°C.
The abdominal cavity was exposed via a midline incision,
both kidneys were exposed and the renal pedicles were
carefully isolated. Bilateral renal occlusion for 30 min was
performed using non-traumatic vascular clamps. Occlu-
sion was confirmed by observing blanching of the entirekidney surface. After removing the renal clips, the kidneys
were observed for a further 5 min to ensure color change
indicating blood reperfusion. Afterwards, 0.5 ml saline at
37°C was injected into the abdomen and the incision was
sutured in two layers [14].
Animals were ethically sacrificed at 24 h after IR injury
and the whole blood drawn from the heart was centri-
fuged at 4°C, 3000 rpm, for 25 min to obtain the serum
sample. The level of serum creatinine (Scr) and blood urea
nitrogen (BUN) was measured by the automatic biochem-
istry analyzer (Hitachi 7060, Hitachi Ltd., Tokyo, Japan).
One kidney was harvested and transversally cut at the
midline. One half was fixed with 10% buffered formalin
for histological assessment, while the rest was frozen
at −80°C for western blot and RT-PCR. The other
kidney and the spleen were kept in phosphate-buffered
saline (PBS) in preparation for flow cytometry analysis.
Single cell suspension preparation and flow cytometry
Spleen and kidney tissue were harvested from mice at
given time points and crushed in mesh bags to obtain
single cell suspensions, in which RBC were lysed with
hypotonic erythrocyte lysis buffer (TIANGEN Biotech,
Beijing, China). Thereafter all single cells were re-
suspended in staining buffer (BD Bioscience, San Diego,
CA, USA). The following monoclonal antibodies (1 mg/
ml; BD PharMingen) were used to identify NKT cells:
FITC-labeled anti-mouse CD3 (Clone: 17A2) and APC-
labeled anti-mouse NK1.1 (Clone: PK136). CXCR3 ex-
pression was determined by PE-labeled anti-mouse
CXCR3 (CD183) (Clone: CXCR3-173). Flow cytometry
data were acquired using BD FACS Aria II (BD Biosci-
ences) and analyzed with FlowJo software 6.0 (Tree Star
Inc., Ashland, OR, USA).
Figure 1 Renal function. Serum creatinine was markedly increased in
IR group compared with Sham group, but after rapamycin treatment,
serum creatinine was significantly reduced (A). Urea nitrogen level
showed the similar trend as serum creatinine (B). Data are expressed as
mean ± SD (n = 5).
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Total RNA was extracted from renal tissues with Trizol
reagent (Invitrogen, Carlsbad, USA). One μg of total
RNA was reverse transcribed into cDNA using a Rever-
tAid™ First Strand cDNA Synthesis Kit (Fermentas, Glen
Burnie, USA). Real-time quantitative PCR (QPCR) was
performed using the SYBR Premix Ex Taq Kit (Takara
Bio Inc., Otsu, Japan) in the ABI Prism 7900HT system
(Applied Biosystems, Foster City, CA, USA). Thermocy-
cler conditions included 2-minute incubation at 50°C,
then 95°C for 10 minutes; this was followed by a 2-step
PCR program, as follows: 95°C for 15 seconds and 60°C
for 60 seconds for 40 cycles. GAPDH was used as anFigure 2 Renal tissue damage and apoptosis. Tubular vacuolation, prot
seen in the IR group. In contrast, less tissue damage was seen after rapamy
at 400× magnification showed that Rapamycin significantly ameliorated kidne
ISEL fragmented DNAs at 400× magnification. They were hardly seen sham g
Rapamycin treatment (C). The number of apoptotic cells was remarkably
mean ± SD (n = 5).internal control to normalize differences in the amount
of total RNA in each sample. Primers are listed in
Table 1.
Western blot
Twenty μg protein from kidney homogenate were sepa-
rated on 15% (wt/vol) poly acrylamide denaturing gels and
electro-blotted onto Hybond-C membranes. These mem-
branes were blocked with 5% (wt/vol) milk, separately
probed with anti-S6RP (Cell Signaling Technology, Boston,
USA) and anti-p-S6RP (Cell Signaling Technology). For
the loading control, the same membranes were probed
with anti-β-actin antibody (1:10,000 dilution, Abcam,
Cambridge, UK), then incubated with peroxidase-conjugated
secondary antibodies (1:10,000 dilution, Jackson Immu-
noResearch, West Grove, USA) at room temperature for
1 h. Immunoreactive bands were visualized using ECL
substrate (Thermo Fisher Scientific, Rockford, USA) and a
Bio-Image Analysis System (Cell Biosciences, Inc., Santa
Clara, USA). The semi-quantitative analysis results were
expressed as optical volume density (OD ×mm2) and nor-
malized by β-actin for loading (AlphaView Software 3.3,
Cell Biosciences, Inc.).
Histological assessment
Renal specimens were fixed in 10% neutral buffered for-
malin and paraffin-embedded. Deparaffinized sections
(5–10 μm) were stained with hematoxylin and eosin (HE).
The tissue sections were blind-labeled and reviewed byein casts, severe inflammatory infiltration as well as haemorrhage were
cin treatment (A). The score of kidney damage assessed in HE sections
y damage compared with IR group (B). Apoptotic cells were detected by
roup, but increased after IR injury, which were markedly decreased after
higher in IR group than in Rapa group (D). Data are expressed as
Figure 3 The proportion of NKT cells in spleen. Lymphocytes were gated from all RBC-free single cell suspensions by FSC and SSC (not showed),
then CD3+ cells were gated in all lymphocytes, and NK1.1+ cells were selected in CD3+ lymphocytes. The proportion of NKT cells (CD3+NK1.1+) in the
spleen was calculated as the proportion of CD3+ cells in all lymphocytes multiplied by the NK1.1+ cells in CD3+ lymphocytes as the total quantity of
splenocytes was manipulated to equal for each test (A). The proportion of NKT cells (CD3+NK1.1+) in spleen was significantly lower in Rapa group than
in IR group (B). Data are expressed as mean ± SD (n = 5).
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to estimate the renal damage, which was graded by the
percentage of tubule injury: 0 (<1%); 1 (1–10%); 2 (11–
20%); 3 (21–40%); 4 (41–60%); 5 (61–75%); 6 (>75%) [15].
The scores represented the severity of tubular injury
(including loss of proximal tubule brush border, cell
swelling or vacuolization, and cell necrosis): the scoreFigure 4 The proportion of NKT cells in peripheral blood. Lymphocyte
CD3+NK1.1+ cells were selected in all lymphocytes. Isotype group was perform
(CD3+NK1.1+) was significantly increased compared with IR group and Sham granges of 1–2 represented mild injury, 3–4 represented
moderate injury, and 5–6 represented severe injury.
In situ end-labeling apoptotic cells
Five micrometer paraffin sections were used to label
fragmented DNAs in situ with digoxigenin-deoxyuridine
(dUTP) by terminal deoxynucleotidyl transferase (TdT)s were gated from all RBC-free single cell suspensions by FSC and SSC, and
ed as control (A). After Rapamycin treatment, the proportion of NKT cells
roup (B). Data are expressed as mean ± SD (n = 5).
Figure 5 The proportion of NKT cells in kidney. Lymphocytes were gated from all RBC-free single cell suspensions by FSC and SSC (not showed),
CD3+ cells were gated in all lymphocytes, and NK1.1+ cells were selected in CD3+ lymphocytes. The proportion of NKT cells (CD3+NK1.1+) in kidney
lymphocytes was calculated as the proportion of CD3+ cells in all lymphocytes multiplied by the NK1.1+ cells in CD3+ lymphocytes (A). The proportion
of NKT cells (CD3+NK1.1+) in kidney tissue was significantly higher in Rapa group than in IR group and Sham group (B). Data are expressed as
mean ± SD (n = 5).
Figure 6 Expression of chemokines in kidney tissue. The expression of NKT trafficking-oriented chemokines in kidney were detected by RT-PCR.
The expression of CXCL9 and CXCL10 was significantly increased after Rapamycin treatment compared with the IR group (A-B), while the expression
of CXCL12, CXCL13, CXCL16 and CCL21 showed no significant difference (C-F). Data are expressed as mean ± SD (n = 5).
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Figure 7 CXCR3 positive NKT cells in kidney lymphocytes. After Rapamycin treatment, CXCR3+ NKT cells in kidney was significantly elevated
compared with IR group and Sham group. Data are expressed as mean ± SD (n = 5).
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USA) [16,17]. Briefly, sections were digested by 40 μg/ml
proteinase K (EMD Chemicals, NJ, USA) for 15 min at
37°C, incubated with TdT and digoxigenin-dUTP at 37°C
for 60 min and transferred to wash/stop buffer for 30 min.
After adding anti-digoxigenin-peroxidase complex for
30 min, these sections were developed by DAB substrate.
Apoptotic cells were examined at 400× magnification over
20 fields for semi-quantitation.Statistical analyses
Statistical analysis of the data was performed with the
two-tailed independent t-test between two groups, using
SPSS 19.0 software (SPSS Inc, Armonk, NY, USA). Values
of P less than 0.01 were considered significant. All values
were presented as mean ± SD.Results
Rapamycin attenuated renal dysfunction, ameliorated
renal histologic damage and apoptosis
Serum creatinine and blood urine nitrogen were markedly
increased by IR injury compared with sham group. After
rapamycin treatment, Scr and BUN level were significantly
reduced compared with the IR group (Figure 1).
Histological assessment in each group was performed
in HE stained sections. There were significant tubular
changes including loss of brush border, dilation of renal tu-
bules, as well as inflammatory infiltration and hemorrhage
in the interstitial area cells following IR injury compared
with the sham group. In contrast, rapamycin treatment sig-
nificantly ameliorated tubular lesions (Figure 2A). The
semi-quantitative assessment of histologic lesion showed a
significantly lower score in the rapamycin group compared
with the IR group post 24 h reperfusion (Figure 2B).Con-
sistently, the number of apoptotic cells, detected by in situ
end-labeling (ISEL) fragmented DNAs, in tubulointerstitial
areas (Figure 2C) was significantly decreased by rapamycin
compared with the IR group (Figure 2D).Rapamycin recruited NKT cells to the IR-injured kidney
To investigate the effect of rapamycin on the trafficking
of NKT cells in IR injury, we analyzed the proportions of
NKT cells in peripheral blood, spleen and kidney. In
spleen, the proportion of NKT cells was decreased in the
IR group compared with the sham group, but the differ-
ence is not significant. Rapamycin, however, significantly
reduced NKT cell proportion (Figure 3). In peripheral
blood, the proportion of NKT cells was raised after IR
injury. After rapamycin treatment, the proportion of
NKT cells was even increased in comparison with the IR
group (Figure 4). Although IR injury induced an increase
of NKT cells in the injured kidney, rapamycin induced a
5.1 fold increase of NKT cells in the kidney compared
with the IR group (Figure 5).Rapamycin-induced NKT cell recruitment to the injured
kidney was mediated by CXCL9, CXCL10 and CXCR3
To verify the chemokines involved in rapamycin-induced
recruitment of NKT cells, the expression of a variety of
chemokines related to NKT cell trafficking was detected
in kidney tissue. The expression of CXCL9 and CXCL10
was significantly increased after rapamycin treatment
compared with the IR group (Figure 6A,B), while the ex-
pression of CXCL12, CXCL13, CXCL16 and CCL21
showed no significant difference (Figure 6C-F). Corres-
pondingly, the expression of CXCR3, which is the receptor
for CXCL9 and CXCL10, was also elevated in rapamycin-
treated group compared with the IR group (Figure 7).Discussion
In this study, we showed that rapamycin was able to re-
cruit NKT cells to the site of injury in the kidney post 24 h
reperfusion. We also demonstrated that this recruitment
was directed by chemokines in terms of CXCL9, CXCL10
and their receptor CXCR3. Our research is the first to re-
veal that rapamycin has an effect on the trafficking process
of renoprotective NKT cells.
Figure 8 The schematics of recruitment of NKT cells to kidney
after rapamycin treatment. After rapamycin treatment, chemokine
CXCL9 and CXCL10 were highly expressed in kidney to create the
gradient of chemokine. The interaction of CXCL9, CXCL10 and their
receptor CXCR3 expressed on NKT cells recruited NKT cells from spleen
via transport of blood to the targeted site of injury where they played
a protective role.
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widely used in anti-allograft rejection after transplant
surgery, but its effect on kidney IR injury still remained
controversial. In our preliminary study, we found that
rapamycin ameliorated renal IR injury in early stage (1 d
after IR injury) while aggravate the injury in late stage (7 d
after IR injury), which was associated with its anti-
apoptotic and anti-survival effects on different stages of IR
injury. In evaluating kidney function 24 h after surgery, this
study found that rapamycin treatment significantly reduced
Scr and BUN concentrations compared with the IR group,
confirming that rapamycin protected kidneys from IR in-
jury in early stage. Accordingly, H&E stained pathological
assessment also showed that rapamycin ameliorated tissue
damage in the kidneys.
NKT cells, expressing both T cell receptors (TCR) and
natural killer cell receptors [18], have been reported to ac-
tively participate in ischemia-reperfusion injury in multiple
solid organs. Cao et al. found that hepatic preconditioning
by preactivation of NKT cells with alpha-GalCer protected
the liver from IR injury via an IL-13 and adenosine A2AR-
dependent mechanism [19]. In kidney, the study from Li
et al. supported the essential role of NKTcells in the innateimmune response of renal IR injury by mediating neutro-
phil infiltration and production of IFN-γ [20]. Consistent
with this, Yang et al. reported that sulfatide-reactive NKT
cells abrogated renal IR Injury. Modulation of cellular infil-
tration and cytokine expressions along with molecular
changes such as HIF-1α and IL-10 were the main mecha-
nisms for protection [13]. NKT cells were key participants
in the early innate response in IR injury and trafficked
post-ischemic kidneys as early as 3 h after IR injury [20].
Our research showed that in the early stage post reperfu-
sion, the proportion of NKT cells was decreased in
spleen and increased in peripheral blood and kidney in
rapamycin-treated group in comparison with the IR
group. This result suggested that rapamycin recruited
NKT cells from spleen where immune cells were stored
to the targeted site of injury through transport of per-
ipheral blood. Thus, we ratiocinate upon the facts men-
tioned above that the renoprotective effect of rapamycin
in the early stage probably has close connection with its
influence on NKT cell trafficking to the site of injury. Our
results demonstrated that the recruitment process was di-
rected by CXCL9, CXCL10 and CXCR3 interaction, while
other NKT trafficking-related chemokines like CXCL12,
CXCL13, CXCL16 and CCL21 may not be involved in this
process. Rapamycin treatment enhanced the expression of
CXCL9 and CXCL10 in the IR-induced kidney, thereby cre-
ating the chemokine gradient between kidney internal and
external tissues. Accordingly, CXCR3+ NKT cells in kidney
were also increased after rapamycin treatment. Thus,
CXCL9 and CXCL10 interacted with the corresponding re-
ceptor CXCR3 expressed on NKT cells to recruit NKT cells
to IR-induced kidney where they are able to play a protect-
ive role (Figure 8). Although the increased CXCL9 and
CXCL10 expression was observed in our study, the mech-
anism that rapamycin increases the expression of CXCL9
and CXCL10 in IR-induced kidney needs to be further in-
vestigated, which was the limitation of this study.
Conclusions
Our study demonstrated that rapamycin was capable of
ameliorating renal IR injury in early stage and recruiting
NKT cells to IR-induced kidney by CXCL9/10 and CXCR3
interaction. The recruitment of renoprotective NKT cells
may account for the protective role of rapamycin. Thus,
this study provided an experimental insight for rapamycin
as a decent choice for the immunosuppresive regimen in
the early stage after renal transplantation. In the future,
further investigation aims to reveal the mechanism behind
the fact that rapamycin could upregulate the expression
certain chemokines to draw NKT cells to IR-induced
kidney.
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